YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Halcyon Molecular Quietly Shuts Down Sequencing Operation


August 20, 2012 | Halcyon Molecular, one of the many companies that was working on next-generation DNA sequencing technologies, has quietly ceased operations due to a shortage of funds, GigaOM reports. The company, advised by Harvard Medical School's George Church, had raised upwards of $20 million in funding from Founders Fund, Elon Musk and others. GigaOM
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.